{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:09:12Z","timestamp":1792069752652,"version":"4.4.0"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01HL151407"],"award-info":[{"award-number":["R01HL151407"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R56DK140968"],"award-info":[{"award-number":["R56DK140968"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM121334"],"award-info":[{"award-number":["P20GM121334"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypertensive disorders of pregnancy (HDPs) are a leading cause of maternal and perinatal morbidity and mortality globally, affecting up to 10% of pregnancies. As rates of obesity, chronic hypertension, and advanced maternal age continue to rise, the burden of HDPs is expected to escalate. This review provides a comprehensive overview of HDPs, encompassing updated classification systems, risk factors, and diagnostic approaches, including emerging biomarkers and predictive imaging tools. We highlight the complex pathophysiology involving impaired placentation, angiogenic imbalance, immune dysregulation, oxidative stress, mitochondrial dysfunction, and epigenetic modifications. Current management strategies are discussed alongside evolving therapeutic interventions, including low-dose aspirin, statins, and novel agents such as hydrogen sulfide donors and C-type natriuretic peptide. Special emphasis is placed on racial, ethnic, and socioeconomic disparities that contribute to disproportionate outcomes, particularly among Black and Indigenous women. We also explore the role of personalized medicine, predictive models, and digital health tools in transforming HDP care. By integrating mechanistic insight with public health strategies and clinical innovation, this review aims to inform multidisciplinary approaches to reduce the burden of HDPs and promote equitable maternal and neonatal outcomes.<\/jats:p>","DOI":"10.1093\/ajh\/hpaf080","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T08:32:49Z","timestamp":1746174769000},"page":"3-14","source":"Crossref","is-referenced-by-count":10,"title":["Hypertensive Pregnancy Disorders: From Mechanisms to Management"],"prefix":"10.1093","volume":"39","author":[{"given":"Marcus K","family":"Robbins","sequence":"first","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen","family":"Nembaware","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sautan","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anukool","family":"Bhopatkar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azaziah","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Chambers","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chas","family":"Brewerton","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mauroner","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline","family":"Deer","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]},{"name":"Department of Obstetrics & Gynecology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6730-6499","authenticated-orcid":false,"given":"Denise C","family":"Cornelius","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]},{"name":"Department of Emergency Medicine, University of Mississippi Medical Center , Jackson, MS ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"2026011413230584600_CIT0001","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for International Practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0003","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"2026011413230584600_CIT0004","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2026011413230584600_CIT0005","volume-title":"Hypertension in Pregnancy","year":"2019"},{"key":"2026011413230584600_CIT0006","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"USPSTF recommendation: aspirin use to prevent preeclampsia","volume":"326","author":"Davidson","year":"2021","journal-title":"J Am Med Assoc"},{"key":"2026011413230584600_CIT0007","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/jog.14425","article-title":"Screening for pre-eclampsia: performance of National Institute for Health and Care Excellence guidelines versus American College of Obstetricians and Gynecologists recommendations","volume":"46","author":"Phumsiripaiboon","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"2026011413230584600_CIT0008","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2023.16991","article-title":"Screening for hypertensive disorders of pregnancy: US Preventive Services Task Force Final Recommendation Statement","volume":"330","author":"Force USPST","year":"2023","journal-title":"J Am Med Assoc"},{"key":"2026011413230584600_CIT0009","doi-asserted-by":"crossref","first-page":"103780","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2022","journal-title":"eBioMedicine"},{"key":"2026011413230584600_CIT0010","first-page":"e944104-1","article-title":"Biomarkers for early prediction and management of preeclampsia: A comprehensive review","volume-title":"Med Sci Monit","author":"Tomkiewicz","year":"2024"},{"key":"2026011413230584600_CIT0011","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1034\/j.1600-0412.1998.770805.x","article-title":"Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia","volume":"77","author":"Pettersson","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026011413230584600_CIT0012","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2024.07.015","article-title":"Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1\/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy","volume":"232","author":"Burns","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"2026011413230584600_CIT0013","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jogc.2017.07.014","article-title":"First and second trimester serum sFlt-1\/PlGF ratio and subsequent preeclampsia: a systematic review","volume":"40","author":"Yusuf","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"2026011413230584600_CIT0014","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"2026011413230584600_CIT0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/eme07080","article-title":"Mini-combined test compared with NICE guidelines for early risk-assessment for pre-eclampsia: the SPREE diagnostic accuracy study","volume":"7","author":"Poon","year":"2020","journal-title":"Efficacy Mechanism Eval"},{"key":"2026011413230584600_CIT0016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"Sotiriadis","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026011413230584600_CIT0017","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"2026011413230584600_CIT0018","doi-asserted-by":"crossref","first-page":"1144170","DOI":"10.3389\/fmed.2023.1144170","article-title":"Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum","volume":"10","author":"Bisson","year":"2023","journal-title":"Front Med"},{"key":"2026011413230584600_CIT0019","doi-asserted-by":"crossref","first-page":"1060253","DOI":"10.3389\/fendo.2023.1060253","article-title":"Hyperglycemia disturbs trophoblast functions and subsequently leads to failure of uterine spiral artery remodeling","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026011413230584600_CIT0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ijgo.12424","article-title":"Role of angiogenic factors in the pathogenesis and management of pre-eclampsia","volume":"141","author":"Ngene","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"2026011413230584600_CIT0021","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41581-022-00670-0","article-title":"The role of immune cells and mediators in preeclampsia","volume":"19","author":"Deer","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"2026011413230584600_CIT0022","doi-asserted-by":"crossref","first-page":"1130116","DOI":"10.3389\/fphys.2023.1130116","article-title":"Setting a stage: inflammation during preeclampsia and postpartum","volume":"14","author":"Herrock","year":"2023","journal-title":"Front Physiol"},{"key":"2026011413230584600_CIT0023","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/antiox11020210","article-title":"Is mitochondrial oxidative stress a viable therapeutic target in preeclampsia","volume":"11","author":"Vaka","year":"2022","journal-title":"Antioxidants"},{"key":"2026011413230584600_CIT0024","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/1389201019666180925121254","article-title":"The role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathophysiology of preeclampsia","volume":"19","author":"Campbell","year":"2018","journal-title":"Curr Pharm Biotechnol"},{"key":"2026011413230584600_CIT0025","doi-asserted-by":"crossref","first-page":"107372","DOI":"10.1016\/j.vph.2024.107372","article-title":"Relevance of real-time analyzers to determine mitochondrial quality in endothelial cells and oxidative stress in preeclampsia","volume":"155","author":"Nunes","year":"2024","journal-title":"Vascul Pharmacol"},{"key":"2026011413230584600_CIT0026","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/biology14030240","article-title":"Extracellular vesicles and pregnancy-related hypertensive disorders: a descriptive review on the possible implications \u201cFrom Bench to Bedside.\u201d","volume":"14","author":"Grossini","year":"2025","journal-title":"Biology"},{"key":"2026011413230584600_CIT0027","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2026011413230584600_CIT0028","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.116.07862","article-title":"The CHIPS randomized controlled trial (control of hypertension in pregnancy study): is severe hypertension just an elevated blood pressure","volume":"68","author":"Magee","year":"2016","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0029","doi-asserted-by":"crossref","first-page":"481.e1","DOI":"10.1016\/j.ajog.2008.07.048","article-title":"Diagnosis and management of atypical preeclampsia-eclampsia","volume":"200","author":"Sibai","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"2026011413230584600_CIT0030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"2026011413230584600_CIT0031","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/1471-0528.12629","article-title":"Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health","volume":"121","author":"Abalos","year":"2014","journal-title":"BJOG"},{"key":"2026011413230584600_CIT0032","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2026011413230584600_CIT0033","first-page":"1","article-title":"WHO Guidelines Approved by the Guidelines Review Committee","volume-title":"WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia","author":"World Health Organization","year":"2011"},{"key":"2026011413230584600_CIT0034","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/jwh.2019.7671","article-title":"Preeclamptic women are at significantly higher risk of future cardiovascular outcomes over a 15-year period","volume":"29","author":"Gastrich","year":"2020","journal-title":"J Womens Health"},{"key":"2026011413230584600_CIT0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/OGX.0000000000000846","article-title":"The impact of preeclampsia on women\u2019s health: cardiovascular long-term implications","volume":"75","author":"Orabona","year":"2020","journal-title":"Obstet Gynecol Surv"},{"key":"2026011413230584600_CIT0036","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/HYPERTENSIONAHA.123.21061","article-title":"Long-term impacts of preeclampsia on the cardiovascular system of mother and offspring","volume":"80","author":"Yang","year":"2023","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0037","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"2026011413230584600_CIT0038","doi-asserted-by":"crossref","first-page":"k4109","DOI":"10.1136\/bmj.k4109","article-title":"Pre-eclampsia and risk of dementia later in life: nationwide cohort study","volume":"363","author":"Basit","year":"2018","journal-title":"Br Med J"},{"key":"2026011413230584600_CIT0039","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/HYPERTENSIONAHA.118.11513","article-title":"Preeclampsia and cerebrovascular disease","volume":"74","author":"Miller","year":"2019","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0040","doi-asserted-by":"crossref","first-page":"257.e251","DOI":"10.1016\/j.ajog.2014.02.031","article-title":"Cerebral white matter lesions and perceived cognitive dysfunction: the role of pregnancy","volume":"211","author":"Postma","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"2026011413230584600_CIT0041","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3174\/ajnr.A4640","article-title":"Brain structural and vascular anatomy is altered in offspring of pre-eclamptic pregnancies: a pilot study","volume":"37","author":"R\u00e4tsep","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"2026011413230584600_CIT0042","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/HYPERTENSIONAHA.119.14280","article-title":"Hypertensive complications of pregnancy and risk of venous thromboembolism","volume":"75","author":"Scheres","year":"2020","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0043","doi-asserted-by":"crossref","first-page":"e0281952","DOI":"10.1371\/journal.pone.0281952","article-title":"Clinical presentation, maternal-fetal, and neonatal outcomes of early-onset versus late onset preeclampsia-eclampsia syndrome in a teaching hospital in a low-resource setting: a retrospective cohort study","volume":"18","author":"Teka","year":"2023","journal-title":"PLoS One"},{"key":"2026011413230584600_CIT0044","first-page":"167","article-title":"Health disparities: gaps in access, quality and affordability of medical care","volume":"123","author":"Riley","year":"2012","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2026011413230584600_CIT0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/a-1886-5404","article-title":"The association of race and ethnicity with severe maternal morbidity among individuals diagnosed with hypertensive disorders of pregnancy","volume":"40","author":"Palatnik","year":"2023","journal-title":"Am J Perinatol"},{"key":"2026011413230584600_CIT0046","doi-asserted-by":"crossref","first-page":"585","DOI":"10.15585\/mmwr.mm7117a1","article-title":"Hypertensive disorders in pregnancy and mortality at delivery hospitalization\u2014United States, 2017-2019","volume":"71","author":"Ford","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026011413230584600_CIT0047","first-page":"283","article-title":"Racial\/ethnic differences in pregnancy-related hypertensive disease in nulliparous women","volume":"24","author":"Ghosh","year":"2014","journal-title":"Ethn Dis"},{"key":"2026011413230584600_CIT0048","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/jcm9051414","article-title":"Racial disparity in pregnancy risks and complications in the US: temporal changes during 2007-2018","volume":"9","author":"Bornstein","year":"2020","journal-title":"J Clin Med"},{"key":"2026011413230584600_CIT0049","doi-asserted-by":"crossref","first-page":"197.e1","DOI":"10.1016\/j.ajog.2007.04.036","article-title":"The \u201cHispanic paradox\u201d: an investigation of racial disparity in pregnancy outcomes at a tertiary care medical center","volume":"197","author":"Brown","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2026011413230584600_CIT0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2105\/AJPH.2005.068577","article-title":"Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study","volume":"97","author":"Tanaka","year":"2007","journal-title":"Am J Public Health"},{"key":"2026011413230584600_CIT0051","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2105\/AJPH.2021.306375","article-title":"Racial and ethnic disparities in maternal mortality in the United States using enhanced vital records, 2016\u20122017","volume":"111","author":"MacDorman","year":"2021","journal-title":"Am J Public Health"},{"key":"2026011413230584600_CIT0052","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11886-022-01826-x","article-title":"Racial and ethnic disparities in hypertension: barriers and opportunities to improve blood pressure control","volume":"25","author":"Abrahamowicz","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"2026011413230584600_CIT0053","doi-asserted-by":"crossref","first-page":"e010282","DOI":"10.1161\/JAHA.118.010282","article-title":"Effects of a community population health initiative on blood pressure control in Latinos","volume":"7","author":"Langabeer","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026011413230584600_CIT0054","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2105\/AJPH.2019.305450","article-title":"Addressing health disparities through deliberative methods: citizens\u2019 panels for health equity","volume":"110","author":"Subica","year":"2020","journal-title":"Am J Public Health"},{"key":"2026011413230584600_CIT0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2105\/AJPH.2019.305493","article-title":"Engaging community members to eradicate health disparities","volume":"110","author":"Morain","year":"2020","journal-title":"Am J Public Health"},{"key":"2026011413230584600_CIT0056","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/ajh\/hpu233","article-title":"Reducing racial and ethnic disparities in hypertension prevention and control: what will it take to translate research into practice and policy","volume":"28","author":"Mueller","year":"2015","journal-title":"Am J Hypertens"},{"key":"2026011413230584600_CIT0057","doi-asserted-by":"crossref","first-page":"468.e1","DOI":"10.1016\/j.amjmed.2010.11.024","article-title":"Racial differences in two self-management hypertension interventions","volume":"124","author":"Bosworth","year":"2011","journal-title":"Am J Med"},{"key":"2026011413230584600_CIT0058","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12884-022-04573-7","article-title":"Pre-pregnancy blood pressure and pregnancy outcomes: a nationwide population-based study","volume":"22","author":"Jung","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026011413230584600_CIT0059","first-page":"201","article-title":"Updated Methodology to Estimate Overall and Unintended Pregnancy Rates in the United States","volume-title":"Vital and Health Statistics Series","author":"Rossen","year":"2023"},{"key":"2026011413230584600_CIT0060","author":"McFarlane","year":"2022","journal-title":"State of World Population Report\u2014Seeing the Unseen: The Case for Action in the Neglected Crisis of Unintended Pregnancy"},{"key":"2026011413230584600_CIT0061","doi-asserted-by":"crossref","first-page":"e2351166","DOI":"10.1001\/jamanetworkopen.2023.51166","article-title":"Mediating factors in the association of maternal educational level with pregnancy outcomes: a Mendelian randomization study","volume":"7","author":"Rogne","year":"2024","journal-title":"JAMA Network Open"},{"key":"2026011413230584600_CIT0062","doi-asserted-by":"crossref","first-page":"886679","DOI":"10.3389\/fcvm.2022.886679","article-title":"Impact of educational interventions on knowledge about hypertensive disorders of pregnancy among pregnant women: a systematic review","volume":"9","author":"Gholami","year":"2022","journal-title":"Front Cardiovas Med"},{"key":"2026011413230584600_CIT0063","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/bmb\/ldy035","article-title":"The management of hypertension in women planning for pregnancy","volume":"128","author":"Lu","year":"2018","journal-title":"Br Med Bull"},{"key":"2026011413230584600_CIT0064","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/advances\/nmab057","article-title":"Maternal dietary patterns and pregnancy hypertension in low- and middle-income countries: a systematic review and meta-analysis","volume":"12","author":"Kinshella","year":"2021","journal-title":"Adv Nutr"},{"key":"2026011413230584600_CIT0065","doi-asserted-by":"crossref","first-page":"e029848","DOI":"10.1161\/JAHA.123.029848","article-title":"Maternal dietary patterns during pregnancy are linked to hypertensive disorders of pregnancy among a predominantly low-income US Hispanic\/Latina pregnancy cohort","volume":"13","author":"Maldonado","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026011413230584600_CIT0066","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(18)30311-8","article-title":"Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health","volume":"391","author":"Stephenson","year":"2018","journal-title":"Lancet"},{"key":"2026011413230584600_CIT0067","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik Daniel","year":"2017","journal-title":"N Engl J Med"},{"key":"2026011413230584600_CIT0068","first-page":"CD001059","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","volume":"10","author":"Hofmeyr","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2026011413230584600_CIT0069","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/ijms19051496","article-title":"Oxidative stress in preeclampsia and placental diseases","volume":"19","author":"Aouache","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026011413230584600_CIT0070","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)80010-5","article-title":"Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial","volume":"354","author":"Chappell","year":"1999","journal-title":"Lancet"},{"key":"2026011413230584600_CIT0071","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3945\/ajcn.111.027995","article-title":"Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials","volume":"95","author":"Juraschek","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"2026011413230584600_CIT0072","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/HYPERTENSIONAHA.119.14598","article-title":"Animal models of preeclampsia","volume":"75","author":"Gatford","year":"2020","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0073","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41371-021-00637-x","article-title":"Progress in preeclampsia: the contribution of animal models","volume":"36","author":"Chau","year":"2022","journal-title":"J Hum Hypertens"},{"key":"2026011413230584600_CIT0074","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.preghy.2019.10.001","article-title":"The Reduced Uterine Perfusion Pressure (RUPP) rat model of preeclampsia exhibits impaired systolic function and global longitudinal strain during pregnancy","volume":"18","author":"Bakrania","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"2026011413230584600_CIT0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/HYPERTENSIONAHA.118.11290","article-title":"Role of mitochondrial dysfunction and reactive oxygen species in mediating hypertension in the Reduced Uterine Perfusion Pressure rat model of preeclampsia","volume":"72","author":"Vaka","year":"2018","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0076","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00117.2012","article-title":"A model of preeclampsia in rats: the Reduced Uterine Perfusion Pressure (RUPP) model","volume":"303","author":"Li","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026011413230584600_CIT0077","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1152\/ajpregu.00377.2014","article-title":"The Dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia","volume":"309","author":"Gillis","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026011413230584600_CIT0078","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1152\/ajpregu.00298.2020","article-title":"Immunological comparison of pregnant Dahl salt-sensitive and Sprague-Dawley rats commonly used to model characteristics of preeclampsia","volume":"321","author":"Taylor","year":"2021","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026011413230584600_CIT0079","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/biology10111179","article-title":"The BPH\/5 mouse model of superimposed preeclampsia is not a model of HELLP syndrome","volume":"10","author":"Johnston","year":"2021","journal-title":"Biology"},{"key":"2026011413230584600_CIT0080","doi-asserted-by":"crossref","first-page":"e202201517","DOI":"10.26508\/lsa.202201517","article-title":"The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health","volume":"5","author":"de Alwis","year":"2022","journal-title":"Life Sci Alliance"},{"key":"2026011413230584600_CIT0081","first-page":"CD006490","article-title":"Nitric oxide for preventing pre-eclampsia and its complications","volume":"2007","author":"Meher","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2026011413230584600_CIT0082","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1681\/ASN.2020070969","article-title":"Macula Densa NOS1\u03b2 modulates renal hemodynamics and blood pressure during pregnancy: role in gestational hypertension","volume":"32","author":"Wei","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026011413230584600_CIT0083","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1073\/pnas.1309561110","article-title":"Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction","volume":"110","author":"Plaks","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026011413230584600_CIT0084","doi-asserted-by":"crossref","first-page":"681632","DOI":"10.3389\/fphys.2021.681632","article-title":"Current state of preeclampsia mouse models: approaches, relevance, and standardization","volume":"12","author":"Waker","year":"2021","journal-title":"Front Physiol"},{"key":"2026011413230584600_CIT0085","doi-asserted-by":"crossref","first-page":"e0253453","DOI":"10.1371\/journal.pone.0253453","article-title":"Genotypic analysis of the female BPH\/5 mouse, a model of superimposed preeclampsia","volume":"16","author":"Sones","year":"2021","journal-title":"PLoS One"},{"key":"2026011413230584600_CIT0086","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/hy02t2.102904","article-title":"Discovery of a spontaneous genetic mouse model of preeclampsia","volume":"39","author":"Davisson","year":"2002","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0087","first-page":"782","article-title":"Managing chronic hypertension in pregnant women: ACOG releases updated practice bulletin","volume":"100","author":"Croke","year":"2019","journal-title":"Am Fam Physician"},{"key":"2026011413230584600_CIT0088","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fcvm.2018.00050","article-title":"Use of antihypertensive drugs during preeclampsia","volume":"5","author":"Odigboegwu","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"2026011413230584600_CIT0089","first-page":"e17322","article-title":"Efficacy of magnesium sulfate on maternal mortality in eclampsia","volume":"13","author":"Padda","year":"2021","journal-title":"Cureus"},{"key":"2026011413230584600_CIT0090","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"key":"2026011413230584600_CIT0091","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12916-022-02582-z","article-title":"Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles","volume":"20","author":"McDougall","year":"2022","journal-title":"BMC Med"},{"key":"2026011413230584600_CIT0092","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejogrb.2024.10.052","article-title":"The effectiveness of low-dose aspirin for the prevention of hypertensive disorders of pregnancy in a sub-Saharan Africa Country: a randomized clinical trial","volume":"303","author":"Mkhize","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026011413230584600_CIT0093","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","article-title":"Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae","volume":"327","author":"Wallenburg","year":"1986","journal-title":"Lancet"},{"key":"2026011413230584600_CIT0094","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026011413230584600_CIT0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"2026011413230584600_CIT0096","doi-asserted-by":"crossref","first-page":"S1171","DOI":"10.1016\/j.ajog.2020.08.040","article-title":"The role of statins in the prevention of preeclampsia","volume":"226","author":"Smith","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2026011413230584600_CIT0097","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","article-title":"Understanding the molecular mechanisms of statin pleiotropic effects","volume":"97","author":"German","year":"2023","journal-title":"Arch Toxicol"},{"key":"2026011413230584600_CIT0098","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/HYPERTENSIONAHA.123.22457","article-title":"Statins prevent the deleterious consequences of placental chemerin upregulation in preeclampsia","volume":"81","author":"Tan","year":"2024","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0099","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/1471-0528.17393","article-title":"Statins in pre-eclampsia or fetal growth restriction: a systematic review and meta-analysis on maternal blood pressure and fetal growth across species","volume":"130","author":"Meijerink","year":"2023","journal-title":"BJOG"},{"key":"2026011413230584600_CIT0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjmed.2022.08.029","article-title":"Update on statin use in pregnancy","volume":"136","author":"Poornima","year":"2023","journal-title":"Am J Med"},{"key":"2026011413230584600_CIT0101","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.placenta.2012.02.014","article-title":"Hydrogen sulfide producing enzymes in pregnancy and preeclampsia","volume":"33","author":"Holwerda","year":"2012","journal-title":"Placenta"},{"key":"2026011413230584600_CIT0102","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1073\/pnas.0908047106","article-title":"Hydrogen sulfide is an endogenous stimulator of angiogenesis","volume":"106","author":"Papapetropoulos","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026011413230584600_CIT0103","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/biolre\/ioae103","article-title":"H2S donor GYY4137 mitigates sFlt-1-induced hypertension and vascular dysfunction in pregnant rats\u2020","volume":"111","author":"Yadav","year":"2024","journal-title":"Biol Reprod"},{"key":"2026011413230584600_CIT0104","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/HYPERTENSIONAHA.124.22838","article-title":"Novel role of 5-methyl-(6S)-tetrahydrofolate in mediating endothelial cell tetrahydrobiopterin in pregnancy and implications for gestational hypertension","volume":"81","author":"Dickinson","year":"2024","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0105","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.118.036344","article-title":"Endothelial C-type natriuretic peptide is a critical regulator of angiogenesis and vascular remodeling","volume":"139","author":"Bubb","year":"2019","journal-title":"Circulation"},{"key":"2026011413230584600_CIT0106","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/HYPERTENSIONAHA.124.22820","article-title":"Exploring the therapeutic potential of C-type natriuretic peptide for preeclampsia","volume":"81","author":"Fato","year":"2024","journal-title":"Hypertension"},{"key":"2026011413230584600_CIT0107","doi-asserted-by":"crossref","first-page":"S454","DOI":"10.1016\/j.hlc.2024.06.709","article-title":"Activation of the C-type natriuretic peptide pathway offers a novel therapeutic target for gestational hypertension","volume":"33","author":"Barsha","year":"2024","journal-title":"Heart Lung Circ"},{"key":"2026011413230584600_CIT0108","doi-asserted-by":"crossref","first-page":"e03","DOI":"10.15420\/usc.2023.01","article-title":"Hypertensive disorders of pregnancy: a literature review\u2014pathophysiology, current management, future perspectives, and healthcare disparities","volume":"18","author":"Traub","year":"2024","journal-title":"US Cardiol"},{"key":"2026011413230584600_CIT0109","doi-asserted-by":"crossref","first-page":"e0300201","DOI":"10.1371\/journal.pone.0300201","article-title":"Machine learning-based models to predict the conversion of normal blood pressure to hypertension within 5-year follow-up","volume":"19","author":"Andishgar","year":"2024","journal-title":"PLoS One"},{"key":"2026011413230584600_CIT0110","doi-asserted-by":"crossref","first-page":"100386","DOI":"10.1016\/j.xagr.2024.100386","article-title":"Using machine learning to predict the risk of developing hypertensive disorders of pregnancy using a contemporary nulliparous cohort","volume":"4","author":"Schor","year":"2024","journal-title":"AJOG Glob Rep"},{"key":"2026011413230584600_CIT0111","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/s41440-023-01348-1","article-title":"Machine learning-based protein signatures for differentiating hypertensive disorders of pregnancy","volume":"46","author":"Varghese","year":"2023","journal-title":"Hypertens Res"},{"key":"2026011413230584600_CIT0112","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14779072.2023.2223978","article-title":"The role of artificial intelligence in hypertensive disorders of pregnancy: towards personalized healthcare","volume":"21","author":"Alkhodari","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026011413230584600_CIT0113","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12872-020-01428-x","article-title":"A risk factor-based predictive model for new-onset hypertension during pregnancy in Chinese Han women","volume":"20","author":"Hou","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2026011413230584600_CIT0114","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/hr.2016.126","article-title":"Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis","volume":"40","author":"Umesawa","year":"2017","journal-title":"Hypertens Res"},{"key":"2026011413230584600_CIT0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaf080\/63105541\/hpaf080.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/39\/1\/3\/63105541\/hpaf080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/39\/1\/3\/63105541\/hpaf080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:23:24Z","timestamp":1768415004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/39\/1\/3\/8126810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,8]]},"published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaf080","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,5,8]]}}}